These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

523 related items for PubMed ID: 32857920

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Immediate histologic correlation in women with atypical squamous cells of undetermined significance cytology and positive high-risk HPV: A retrospective review of 6000 cases in a large academic women's hospital.
    Zhang H, Pradhan D, Wang T, Ashman D, Matsko J, Zhao C.
    Cancer Cytopathol; 2020 Nov; 128(11):852-859. PubMed ID: 32639689
    [Abstract] [Full Text] [Related]

  • 3. Immediate histopathologic follow-up of cervista and aptima high-risk HPV assays in women with LSIL cytology.
    Zhang H, Varma KR, Han M, Matsko J, Zhao C.
    Cancer Cytopathol; 2018 Aug; 126(8):525-532. PubMed ID: 29797678
    [Abstract] [Full Text] [Related]

  • 4. Presence of koilocytosis in low-grade smears of high-risk HPV-positive women is a negative predictor for cervical intraepithelial neoplasia grade 3 or more.
    Siebers AG, van der Linden H, Vedder JEM, Bekkers RLM, Melchers WLG, Bulten J.
    Cytopathology; 2018 Jun; 29(3):275-280. PubMed ID: 29575519
    [Abstract] [Full Text] [Related]

  • 5. Silent High Grade Cervical Intraepithelial Neoplasia in Atypical Smears from Liquid Based Cervical Cytology - Three Years Experience in Thammasat University Hospital.
    Lertvutivivat S, Chanthasenanont A, Chanthasenanont A, Muangto T, Nanthakomon T, Pongrojpaw D, Bhamarapravatana K, Suwannarurk K.
    Asian Pac J Cancer Prev; 2016 Jun; 17(9):4353-4356. PubMed ID: 27797243
    [Abstract] [Full Text] [Related]

  • 6. Significance of High-Risk Human Papillomavirus Testing for Atypical Glandular Cells on Cervical Cytology.
    Komatsu H, Oishi T, Osaku D, Sawada M, Kudoh A, Nonaka M, Chikumi J, Sato S, Harada T.
    Acta Cytol; 2018 Jun; 62(5-6):405-410. PubMed ID: 29990964
    [Abstract] [Full Text] [Related]

  • 7. HPV detection rates and histopathologic follow-up of patients with HSIL cytology in a large academic women's hospital laboratory.
    Ashman D, Zhang H, Li J, Austin M, Wang T, Pradhan D, Zhao C.
    J Am Soc Cytopathol; 2020 Jun; 9(6):550-555. PubMed ID: 32475726
    [Abstract] [Full Text] [Related]

  • 8. Prediction of cervical intraepithelial neoplasia grade 2+ (CIN2+) using HPV DNA testing after a diagnosis of atypical squamous cell of undetermined significance (ASC-US) in Catalonia, Spain.
    Ibáñez R, Moreno-Crespi J, Sardà M, Autonell J, Fibla M, Gutiérrez C, Lloveras B, Alejo M, Català I, Alameda F, Casas M, Bosch FX, de Sanjosé S.
    BMC Infect Dis; 2012 Jan 26; 12():25. PubMed ID: 22280073
    [Abstract] [Full Text] [Related]

  • 9. Atypical Squamous Cells of Undetermined Significance Cervical Cytology Report Rate and Histologic Follow-up Findings From the Largest College of American Pathologists-Certified Laboratory in China.
    Zheng B, Yang H, Li Z, You J, Wei G, Zhang H, Zeng Z, Xie F, Zhao C.
    Arch Pathol Lab Med; 2019 Jun 26; 143(6):748-752. PubMed ID: 30605022
    [Abstract] [Full Text] [Related]

  • 10. Significance of high-risk human papillomavirus DNA detection in women 50 years and older with squamous cell papanicolaou test abnormalities.
    Zhao C, Zhao S, Heider A, Austin RM.
    Arch Pathol Lab Med; 2010 Aug 26; 134(8):1130-5. PubMed ID: 20670132
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical performance of the Food and Drug Administration-Approved high-risk HPV test for the detection of high-grade cervicovaginal lesions.
    Zhou H, Mody RR, Luna E, Armylagos D, Xu J, Schwartz MR, Mody DR, Ge Y.
    Cancer Cytopathol; 2016 May 26; 124(5):317-23. PubMed ID: 26774025
    [Abstract] [Full Text] [Related]

  • 13. Adjunctive human papillomavirus DNA testing is a useful option in some clinical settings for disease risk assessment and triage of females with ASC-H Papanicolaou test results.
    Bandyopadhyay S, Austin RM, Dabbs D, Zhao C.
    Arch Pathol Lab Med; 2008 Dec 26; 132(12):1874-81. PubMed ID: 19061283
    [Abstract] [Full Text] [Related]

  • 14. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
    Latsuzbaia A, Hebette G, Fischer M, Arbyn M, Weyers S, Vielh P, Schmitt F, Mossong J.
    Diagn Cytopathol; 2017 May 26; 45(5):384-390. PubMed ID: 28247516
    [Abstract] [Full Text] [Related]

  • 15. The reliability of high-risk human papillomavirus detection by Aptima HPV assay in women with ASC-US cytology.
    Castle PE, Reid J, Dockter J, Getman D.
    J Clin Virol; 2015 Aug 26; 69():52-5. PubMed ID: 26209379
    [Abstract] [Full Text] [Related]

  • 16. Comparison of Aptima and hybrid capture-2 HPV tests and Pap test in the referral population in Japan.
    Kuroki H, Sakamoto J, Shibata T, Takakura M, Sasagawa T.
    J Med Virol; 2021 Aug 26; 93(8):5076-5083. PubMed ID: 33634473
    [Abstract] [Full Text] [Related]

  • 17. Aptima HPV messenger RNA testing and histopathologic follow-up in women with HSIL cytology: A study emphasizing additional review of HPV-negative cases.
    Li A, Li J, Austin RM, Wang T, Ashman D, Zhang H, Matsko J, Zhao C.
    Cancer Cytopathol; 2021 Aug 26; 129(8):622-631. PubMed ID: 33764649
    [Abstract] [Full Text] [Related]

  • 18. Experience of Combined Liquid Based Cervical Cytology and High-Risk HPV mRNA for Cervical Cancer Screening in Thammasat University Hospital.
    Muangto T, Chanthasenanont A, Lertvutivivat S, Nanthakomon T, Pongrojpaw D, Bhamarapravatana K, Suwannarurk K.
    Asian Pac J Cancer Prev; 2016 Aug 26; 17(9):4409-4413. PubMed ID: 27797253
    [Abstract] [Full Text] [Related]

  • 19. The APTIMA HPV assay versus the Hybrid Capture 2 test in triage of women with ASC-US or LSIL cervical cytology: a meta-analysis of the diagnostic accuracy.
    Arbyn M, Roelens J, Cuschieri K, Cuzick J, Szarewski A, Ratnam S, Reuschenbach M, Belinson S, Belinson JL, Monsonego J.
    Int J Cancer; 2013 Jan 01; 132(1):101-8. PubMed ID: 22610699
    [Abstract] [Full Text] [Related]

  • 20. Effectiveness of two strategies to follow-up ASC-US and LSIL screening results in The Netherlands using repeat cytology with or without additional hrHPV testing: a retrospective cohort study.
    Siebers AG, Arbyn M, Melchers WJ, van Kemenade FJ, Vedder JE, van der Linden H, van Ballegooijen M, Bekkers RL, Bulten J.
    Cancer Causes Control; 2014 Sep 01; 25(9):1141-9. PubMed ID: 24935226
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.